Sign in

CIK 0002028614 · <br>Emerging growth company

Drugs Made In America Acquisition Corp.

Sign in to watch
Ticker
DMAA
Exchange
Nasdaq
Industry
Blank Checks
FY end
Dec 31
Entity type
operating
Phone
646-726-7074
Business address
420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170

Securities

  • DMAA Ordinary Shares Nasdaq
  • DMAAR Rights Nasdaq
  • DMAAU Units Nasdaq
  1. DEF 14A Proxy Proxy Statement
  2. 8-K Event Other events
  3. NT 10-K Other NT 10-K
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. 8-K Event Material agreement · New debt or obligation · Other events
  6. 8-K Event Other events
  7. 8-K Event Executive or director change
  8. 10-Q Report Quarterly Report
  9. 8-K Event Executive or director change
  10. NT 10-Q Other NT 10-Q
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 10-Q Report Quarterly Report
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 10-Q Report Quarterly Report
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. NT 10-Q Other NT 10-Q
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 2 of 4 · 80 filings